<?xml version="1.0" encoding="UTF-8"?>
<p>One of the reasons for this could be attributed to changes in the caudate nuclei of patients with advanced PD
 <sup>
  <xref rid="bibr23-0963689718820271" ref-type="bibr">23</xref>
 </sup> as well as unattended disturbances of non-dopaminergic neurotransmitter systems within or beyond the basal ganglia which have been linked to PD pathology
 <sup>
  <xref rid="bibr7-0963689718820271" ref-type="bibr">7</xref>,
  <xref rid="bibr24-0963689718820271" ref-type="bibr">24</xref>
 </sup>. An example of such disturbances is a 25% loss of serotonergic receptor 5-HT
 <sub>1A</sub> in the median raphe nucleus/midbrain that has been correlated with the severity of resting tremor
 <sup>
  <xref rid="bibr25-0963689718820271" ref-type="bibr">25</xref>
 </sup>. Putaminal serotonin preservation has been related to L-DOPA-induced dyskinesias
 <sup>
  <xref rid="bibr26-0963689718820271" ref-type="bibr">26</xref>
 </sup>. Decline in serotonin in the subthalamic nucleus is related to PD depression
 <sup>
  <xref rid="bibr27-0963689718820271" ref-type="bibr">27</xref>
 </sup>, and acetylcholine down-regulation in the nucleus basalis of Meynert appears to play a significant role in cognition
 <sup>
  <xref rid="bibr28-0963689718820271" ref-type="bibr">28</xref>
 </sup>, although the temporal relationship of damage to specific neurochemical systems is not well established
 <sup>
  <xref rid="bibr2-0963689718820271" ref-type="bibr">2</xref>
 </sup>.
</p>
